These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 11060669)
1. Drugs in development for the treatment of multiple sclerosis: antigen non-specific therapies--an update. Donoghue S; Greenlees C Expert Opin Investig Drugs; 2000 Jan; 9(1):167-71. PubMed ID: 11060669 [TBL] [Abstract][Full Text] [Related]
2. What is new in the treatment of multiple sclerosis? Weinstock-Guttman B; Jacobs LD Drugs; 2000 Mar; 59(3):401-10. PubMed ID: 10776827 [TBL] [Abstract][Full Text] [Related]
3. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
9. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis. Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858 [TBL] [Abstract][Full Text] [Related]
12. Investigational drug therapies of treatment of multiple sclerosis. Panitch HS Mult Scler; 1996 Sep; 2(2):66-77. PubMed ID: 9345383 [TBL] [Abstract][Full Text] [Related]
13. Editorial: Licensing and Use of New Therapies in MS: Where Are We Going? Hurwitz B Int MS J; 2005 Aug; 12(2):39-41. PubMed ID: 16417813 [No Abstract] [Full Text] [Related]
14. Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics. Rudick RA Arch Neurol; 1999 Sep; 56(9):1079-84. PubMed ID: 10488808 [TBL] [Abstract][Full Text] [Related]
15. Treatment of multiple sclerosis and related disorders: what's new in the past 2 years? Noseworthy JH Clin Neuropharmacol; 2003; 26(1):28-37. PubMed ID: 12567162 [No Abstract] [Full Text] [Related]
16. [New therapeutic agents in the management of multiple sclerosis]. Besson G; Carpentier F Presse Med; 1998 Dec; 27(39):2032-5. PubMed ID: 9893694 [TBL] [Abstract][Full Text] [Related]
17. Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects. Pender MP; Wolfe NP Intern Med J; 2002 Nov; 32(11):554-63. PubMed ID: 12412939 [TBL] [Abstract][Full Text] [Related]
18. The role of interferons in the treatment of multiple sclerosis. Kelley CL J Neurosci Nurs; 1996 Apr; 28(2):114-20. PubMed ID: 8718760 [TBL] [Abstract][Full Text] [Related]
19. Key issues in the diagnosis and treatment of multiple sclerosis. An overview. O'Connor P; Neurology; 2002 Sep; 59(6 Suppl 3):S1-33. PubMed ID: 12448786 [No Abstract] [Full Text] [Related]
20. [New therapeutic strategies in multiple sclerosis]. Berger E; Rumbach L Rev Med Interne; 1999 Aug; 20 Suppl 3():346s-350s. PubMed ID: 10480185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]